An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
read at $41.03
Apellis Pharmaceuticals, Inc. holds its Accumulation at $41.03.
The investor read · the season, not the day
| Phase | Accumulation |
| Quantitative state | Elevated stress, defensive posture warranted, held for 12 days |
| Price | $41.03 |
| Valuation | 38.35 trailing · -120.68 forward price to earnings |
| Values screen | PASS · score 93.6 |
| Beta | -0.25 |
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with near-perfect ethical score (94). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-29 | BAUMAL CAROLINE | Officer | 900 | · | |
| 2026-04-17 | SULLIVAN TIMOTHY EUGENE | Chief Financial Officer | 11,096 | · | |
| 2026-03-11 | FRANCOIS CEDRIC | Chief Executive Officer | 64,869 | · | |
| 2026-02-27 | DOLSTEN MIKAEL G | Director | 14,312 | · | |
| 2026-02-11 | DELONG MARK JEFFREY | Officer | 368 | $8,153 | |
| 2026-02-03 | FRANCOIS CEDRIC | Chief Executive Officer | 8,840 | $33,238 | |
| 2026-01-28 | NICHOLSON NUR | Chief Technology Officer | 45,220 | · | |
| 2026-01-28 | CHOPAS JAMES GEORGE | Officer | 16,150 | · | |
| 2026-01-28 | DELONG MARK JEFFREY | Officer | 36,606 | · | |
| 2026-01-28 | BOUCHER KELLEY | Officer | 30,146 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $40.85 | +0.5% | · | $1,005 | +0.5% |
| 2 months | $18.87 | +117.4% | · | $2,174 | +117.4% |
| 3 months | $21.70 | +89.1% | · | $1,891 | +89.1% |
| 6 months | $20.33 | +101.8% | · | $2,018 | +101.8% |
| 1 year | $16.36 | +150.8% | · | $2,508 | +150.8% |
| 2 years | $41.92 | -2.1% | · | $979 | -2.1% |
| 3 years | $87.68 | -53.2% | · | $468 | -53.2% |
| 5 years | $44.26 | -7.3% | · | $927 | -7.3% |
Historical returns from market close data. Past performance does not guarantee future results.
Get our weekly market brief free.